Sara Puertas

1.2k total citations
16 papers, 703 citations indexed

About

Sara Puertas is a scholar working on Molecular Biology, Biomedical Engineering and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sara Puertas has authored 16 papers receiving a total of 703 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Biomedical Engineering and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sara Puertas's work include Advanced Biosensing Techniques and Applications (4 papers), Advanced biosensing and bioanalysis techniques (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Sara Puertas is often cited by papers focused on Advanced Biosensing Techniques and Applications (4 papers), Advanced biosensing and bioanalysis techniques (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Sara Puertas collaborates with scholars based in Spain, United States and Australia. Sara Puertas's co-authors include Jesús M. de la Fuente, Valeria Grazú, María Moros, Ester Polo, Manel Esteller, Alberto Villanueva, F. Javier Carmona, José M. Guisán, Pilar Batalla and Pablo del Pino and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and ACS Nano.

In The Last Decade

Sara Puertas

16 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Puertas Spain 11 506 181 159 82 68 16 703
Xiangli Bu China 12 473 0.9× 100 0.6× 215 1.4× 114 1.4× 95 1.4× 16 692
Christine Probst United States 12 507 1.0× 172 1.0× 247 1.6× 122 1.5× 58 0.9× 16 827
Andrew Warren United States 13 406 0.8× 98 0.5× 358 2.3× 59 0.7× 35 0.5× 18 802
Sijin Guo United States 11 628 1.2× 128 0.7× 169 1.1× 130 1.6× 18 0.3× 20 793
Haizhen Zhu China 10 405 0.8× 56 0.3× 127 0.8× 89 1.1× 29 0.4× 19 587
Olga S. Kolovskaya Russia 14 464 0.9× 60 0.3× 297 1.9× 97 1.2× 26 0.4× 31 694
Parthapratim Chandaroy United States 7 537 1.1× 227 1.3× 142 0.9× 171 2.1× 28 0.4× 7 853
Galina S. Zamay Russia 15 494 1.0× 59 0.3× 304 1.9× 88 1.1× 28 0.4× 33 716
Paola Gagni Italy 14 594 1.2× 124 0.7× 153 1.0× 44 0.5× 70 1.0× 34 753
Dawn R. Christianson United States 10 308 0.6× 61 0.3× 96 0.6× 76 0.9× 77 1.1× 13 542

Countries citing papers authored by Sara Puertas

Since Specialization
Citations

This map shows the geographic impact of Sara Puertas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Puertas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Puertas more than expected).

Fields of papers citing papers by Sara Puertas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Puertas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Puertas. The network helps show where Sara Puertas may publish in the future.

Co-authorship network of co-authors of Sara Puertas

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Puertas. A scholar is included among the top collaborators of Sara Puertas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Puertas. Sara Puertas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Abad, José M., et al.. (2021). Design and Development of Antibody Functionalized Gold Nanoparticles for Biomedical Applications. Journal of Nanoscience and Nanotechnology. 21(5). 2834–2840. 1 indexed citations
2.
Puertas, Sara, Lucía Gutiérrez, Laura Asín, et al.. (2019). Design of stable magnetic hybrid nanoparticles of Si-entrapped HRP. PLoS ONE. 14(4). e0214004–e0214004. 13 indexed citations
3.
Barrio, Melisa del, María Moros, Sara Puertas, et al.. (2017). Glucose oxidase immobilized on magnetic nanoparticles: Nanobiosensors for fluorescent glucose monitoring. Microchimica Acta. 184(5). 1325–1333. 9 indexed citations
4.
Moros, María, Sara Puertas, Berta Sáez, et al.. (2015). Surface engineered magnetic nanoparticles for specific immunotargeting of cadherin expressing cells. Journal of Physics D Applied Physics. 49(5). 54003–54003. 6 indexed citations
5.
Ambrogio, Chiara, Francisco javier García Carmona, August Vidal, et al.. (2014). Modeling Lung Cancer Evolution and Preclinical Response by Orthotopic Mouse Allografts. Cancer Research. 74(21). 5978–5988. 18 indexed citations
6.
Polo, Ester, Sara Puertas, María Moros, et al.. (2013). Tips for the Functionalization of Nanoparticles with Antibodies. Methods in molecular biology. 1051. 149–163. 26 indexed citations
7.
Carmona, F. Javier, Alberto Villanueva, August Vidal, et al.. (2012). Epigenetic disruption of cadherin‐11 in human cancer metastasis. The Journal of Pathology. 228(2). 230–240. 48 indexed citations
8.
Puertas, Sara, Ernest Mendoza, Cecilia Jiménez‐Jorquera, et al.. (2012). Improving immunosensor performance through oriented immobilization of antibodies on carbon nanotube composite surfaces. Biosensors and Bioelectronics. 43. 274–280. 45 indexed citations
9.
Kosaka, Priscila M., Javier Tamayo, J. J. Ruz, et al.. (2012). Tackling reproducibility in microcantilever biosensors: a statistical approach for sensitive and specific end-point detection of immunoreactions. The Analyst. 138(3). 863–872. 19 indexed citations
10.
Taniguchi, Hiroaki, Filipe V. Jacinto, Alberto Villanueva, et al.. (2011). Silencing of Kruppel-like factor 2 by the histone methyltransferase EZH2 in human cancer. Oncogene. 31(15). 1988–1994. 86 indexed citations
11.
Lavilla, María, María Moros, Sara Puertas, et al.. (2011). Specific peptides as alternative to antibody ligands for biomagnetic separation of Clostridium tyrobutyricum spores. Analytical and Bioanalytical Chemistry. 402(10). 3219–3226. 8 indexed citations
12.
Puertas, Sara, Pilar Batalla, María Moros, et al.. (2011). Taking Advantage of Unspecific Interactions to Produce Highly Active Magnetic Nanoparticle−Antibody Conjugates. ACS Nano. 5(6). 4521–4528. 136 indexed citations
13.
Melo, Sónia A., Alberto Villanueva, Cátia Moutinho, et al.. (2011). Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing. Proceedings of the National Academy of Sciences. 108(11). 4394–4399. 194 indexed citations
14.
Puertas, Sara, María Moros, Rodrigo Fernández‐Pacheco, et al.. (2010). Designing novel nano-immunoassays: antibody orientation versus sensitivity. Journal of Physics D Applied Physics. 43(47). 474012–474012. 73 indexed citations
15.
Piulats, Josep M., Marga Nadal, María Martínez‐Iniesta, et al.. (2009). Nude mice model of primary human nonseminoma germ cell tumors to study biology and resistance to cisplatin treatment. Journal of Clinical Oncology. 27(15_suppl). e16143–e16143. 1 indexed citations
16.
Font-Llitjós, Mariona, Lídia Feliubadaló, Ramón Clèries, et al.. (2007). Slc7a9knockout mouse is a good cystinuria model for antilithiasic pharmacological studies. American Journal of Physiology-Renal Physiology. 293(3). F732–F740. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026